Patent EP0182315A2 successfully refreshed from Google Patents.
EP0182315A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Novel antibiotic NK84-0218 pharmaceutical compositions containing it and process for the production of the same
Assignee: Nippon Kayaku Co Ltd
•
Filing: 1985-11-16
•
Granted: —
•
Expires: 2005-11-16
Abstract
Abstract This invention relates to a novel antibiotic NK84-0218 of the formula:which exhibits antibacteriel, antiviral and antineoplastic activities, pharmaceutical compositions containing it as well as a process for the production of the same.
Inventors
- 👤 Nobuyoshi Shimada
- 👤 Shigeru Hasegawa
- 👤 Takashi Harada
- 👤 Takayuki Tomizawa
- 👤 Akio Fujii
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-10-31 23:32
CPC Classifications
C; C07; C07H; C07H19/00; C07H19/02; A; A61; A61P; A61P31/00; A61P31/04; A61P31/12; A61P35/00; C12; C12N; C12N1/00; C12N1/20; C12N1/205; C12P; C12P19/00; C12P19/26; C12P19/28; C12P19/38; C12P19/385; C12R; C12R2001/00; C12R2001/01; C12R2001/07; C12R2001/11; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/822; Y10S435/832; Y10S435/837
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
8 words
,(1) A novel antibiotic NK84-0218 of the formula:
Claim 2
Dependent Claim
48 words
(2) A process for production of a novel antibiotic NK84-0218, which comprises culturing a microorganism which belongs to the genus Bacillus and is capable of producing the antibiotic NK84-0218 in a medium to produce and accumulate the antibiotic NK84-0218 in the medium and collecting the antibiotic NK84-0218 therefrom.
Claim 3
Dependent Claim
15 words
(3) A process as set forth in Claim 2 wherein said microorganism is Bacillus megaterium.
Claim 4
Dependent Claim
17 words
(4) A process as set forth in Claim 2 wherein said microorganism is Bacillus megaterium NK84-0218 strain.
Claim 5
Dependent Claim
13 words
(5) Use of the compound as defined in claim 1 as a medicament.
Claim 6
Dependent Claim
23 words
(6) Use of the compound as defined in claiml in the treatment of tumors, diseases caused by bacteria or diseases caused by virus.
Claim 7
Dependent Claim
27 words
(7) A pharmaceutical composition comprising a compound as defined in claim 1, as an effective ingredient, in association with a pharmaceutically acceptable, substantially non-toxic carrier or excipient.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.